OIP — The Opportunity Intelligence PlatformOIP / Government Intelligence
Preparing the stored Government Intelligence discovery view.
OIP / Government Intelligence / Opportunity detail
Source: Stored live-derived Government dataNational Institutes of Health
OIP derived this review page from stored live-derived Government Intelligence source records. The official source and issuing agency remain authoritative.
Opportunity Intelligence Platform is an independent service and is not affiliated with or endorsed by the U.S. Government. Official notices, amendments, attachments, eligibility requirements, funding terms, and deadlines remain under source control.
OIP scores and explanations are informational and do not guarantee eligibility, suitability, compliance, contract award, or financial outcome.
No funding amount is disclosed in the stored source fields.
Public and State controlled institutions of higher education; Independent school districts; Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); Special district governments; For profit organizations other than small businesses; Native American tribal governments (Federally recognized); Public housing authorities/Indian housing authorities; State governments; Private institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); County governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; City or township governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
2 warning(s) require review.
Objective score, derived by OIP
Publication decision: Publish with warning
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) -- a Cooperative Agreement (Cooperative Agreement) issued by National Institutes of Health.
Objective Government score 67 for grants-gov-357019, computed from source evidence and Government scoring configuration.
potential_value (not_applicable): potential_value is structurally not applicable for this Government category.
10 evidence record(s) support this pipeline result.
Next action: Review the official Grants.gov opportunity and follow the listed application package instructions.
95/100 · Ok
evidence_quality scored from source evidence and Government scoring guidance (value kind deterministic_calculation, confidence rank 0).
90/100 · Ok
confidence scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
No numeric value · Not Applicable
potential_value is structurally not applicable for this Government category.
62/100 · Ok
urgency scored from source evidence and Government scoring guidance (value kind deterministic_calculation, confidence rank 0).
56/100 · Ok
difficulty scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
62/100 · Ok
time_required scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
48/100 · Ok
capital_required scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
52/100 · Ok
risk scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
68/100 · Ok
novelty scored from source evidence and Government scoring guidance (value kind rule_based_evaluation, confidence rank 1).
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
$.detail.opportunityTitle · Field Mapping · 98/100 confidence
357019 / PAR-24-325
$.detail.id · Field Mapping · 99/100 confidence
National Institutes of Health
$.detail.synopsis.agencyName · Field Mapping · 97/100 confidence
Cooperative Agreement
$.detail.synopsis.fundingInstruments · Field Mapping · 96/100 confidence
This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 10 years.
$.detail.synopsis.synopsisDesc · Field Mapping · 94/100 confidence
2024-11-06T05:00:00.000Z
$.detail.synopsis.postingDate · Field Mapping · 96/100 confidence
2027-09-07T00:00:00.000Z
$.searchHit.closeDate · Field Mapping · 92/100 confidence
Applicant types: Public and State controlled institutions of higher education; Independent school districts; Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); Special district governments; For profit organizations other than small businesses; Native American tribal governments (Federally recognized); Public housing authorities/Indian housing authorities; State governments; Private institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); County governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; City or township governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Official source materials control eligibility, deadlines, amendments, attachments, and funding terms.
Open official source$.detail.synopsis.applicantTypes · Field Mapping · 94/100 confidence
value_not_disclosed
$.detail.synopsis · Field Mapping · 84/100 confidence
2024-11-06T21:08:53.000Z
$.detail.synopsis.lastUpdatedDate · Field Mapping · 88/100 confidence